Aberdare Ventures
Aberdare Ventures offers the healthcare industry with seed, early, and later stage venture, private equity, and grants investments.
Business Model:
Revenue: $17.6M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Aberdare Ventures Information
Geographic Data
Address: 235 Montgomery St
City: San Francisco
State: CA
Zip: 94104
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Aberdare Ventures is a venture firm that focuses on a limited number of entrepreneurial teams committed to building leading healthcare technology companies. They limit their commitments in the belief that their involvement can increase the probability of success for their portfolio companies and generate greater returns for their investors.
Contact Phone:
+14153927442
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2012 | MC10 | Venture Round | 2M |
| 12/2012 | MC10 | Series C | 10M |
| 7/2007 | Ablation Frontiers | Series C | 0 |
| 12/2012 | goBalto | Series B | 0 |
| 12/2006 | Posit Science | Series B | 14.5M |
| 4/2009 | Posit Science | Venture Round | 5.6M |
| 6/2011 | Aviir | Venture Round | 3M |
| 4/2013 | Cervel Neurotech | Venture Round | 14.1M |
| 3/2014 | Gravie | Series A | 0 |
| 9/1999 | CapitalThinking | Series A | 3.4M |
| 3/2005 | Sequoia Pharmaceuticals | Series B | 22M |
| 6/2002 | Salmedix | Series B | 27.5M |
| 11/2002 | Anacor Pharmaceutical | Venture Round | 4M |
| 6/2008 | VertiFlex | Series C | 28.3M |
| 12/2010 | Jiff | Seed Round | 1M |
| 1/2007 | VertiFlex | Series B | 20M |
| 8/2004 | Avera Pharmaceutical | Series C | 0 |
| 11/2000 | Microbia | Series B | 0 |
| 9/2014 | Jiff | Series B | 0 |
| 9/2013 | Adavium | Private Equity Round | 20M |
| 5/2005 | Anacor Pharmaceutical | Series C | 25M |
| 11/2012 | Wello | Seed Round | 1M |
| 6/2015 | Realeve | Series D | 43.2M |
| 4/2010 | Viracta Therapeutics | Series B | 12M |
| 8/2006 | Kemia | Series C | 0 |
| 2/2011 | VertiFlex | Venture Round | 14M |
| 7/2017 | Gravie | Series C | 0 |
| 3/2012 | Viracta Therapeutics | Series B | 0 |
| 5/2015 | Jiff | Series C | 0 |
| 6/2007 | Paracor Medical | Series D | 44M |
| 10/2011 | Realeve | Series C | 32M |
| 3/2011 | Posit Science | Venture Round | 3.1M |
| 3/2014 | goBalto | Venture Round | 0 |
| 2/2011 | Conatus Pharmaceuticals | Series B | 0 |
| 5/2006 | Eledon Pharmaceuticals | Series B | 35M |
| 3/2012 | Jiff | Series A | 7.5M |
| 4/2015 | Gravie | Series B | 0 |
| 1/2015 | goBalto | Series C | 0 |
| 9/2010 | EnteroMedics | Post-IPO Equity | 6.3M |
| 9/2012 | RxAnte | Series A | 4.6M |
| 10/2009 | Aviir | Venture Round | 1M |
| 12/2008 | Aviir | Venture Round | 7.8M |
| 6/2013 | Aviir | Series B | 10M |
| 1/2010 | Aviir | Venture Round | 4.2M |
| 9/2007 | Aviir | Series B | 11.3M |
| 12/2011 | Aviir | Venture Round | 10M |
| 3/2008 | Aviir | Venture Round | 1.5M |
| 12/2006 | NBI Development | Seed Round | 5.5M |
| 5/2006 | KAI Pharmaceuticals | Series B | 35M |
| 7/2005 | VertiFlex | Series A | 6.3M |
| 1/2009 | Anacor Pharmaceutical | Series E | 0 |
| 9/2018 | Cricket Health | Series A | 0 |
| 1/2007 | Sequoia Pharmaceuticals | Series C | 35M |
| 10/2011 | NxThera | Series B | 0 |
| 9/2013 | Advance Medical | Series B | 20M |
| 2/2009 | Mpex Pharmaceuticals | Series D | 27.5M |
| 7/2002 | Anacor Pharmaceutical | Series A | 2.9M |
| 12/2001 | Pharmion | Venture Round | 65M |
| 4/2000 | Alibris | Series D | 30M |
| 7/2011 | Nevro | Series B | 58M |
| 6/2004 | Idun Pharmaceuticals | Venture Round | 0 |
| 12/2006 | Nevro | Seed Round | 5.5M |
| 9/2008 | Nevro | Series A | 21.8M |
| 8/2018 | MC10 | Venture Round | 0 |
| 1/2011 | Rock Health | Grant | 0 |
| 5/2009 | Clovis Oncology | Venture Round | 145M |
| 12/2011 | Omada Health | Seed Round | 800k |
| 5/2007 | Conatus Pharmaceuticals | Series A | 22M |
| 5/2015 | Realeve | Series D | 38M |
| 2/2013 | Aviir | Series B | 10M |
| 8/2005 | Mpex Pharmaceuticals | Series B | 0 |
| 9/2008 | Cervel Neurotech | Series A | 1.5M |
| 10/2012 | Bluesight | Seed Round | 100k |
| 9/2018 | Cricket Health | Series A | 0 |
| 8/2018 | MC10 | Venture Round | 0 |
| 7/2017 | Gravie | Series C | 0 |
| 6/2015 | Realeve | Series D | 0 |
| 5/2015 | Jiff | Series C | 0 |
| 5/2015 | Realeve | Series D | 0 |
| 4/2015 | Gravie | Series B | 0 |
| 1/2015 | goBalto | Series C | 0 |
| 9/2014 | Jiff | Series B | 0 |
| 3/2014 | Gravie | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
